These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 17504322)

  • 1. Differences in toxicity across gender in patients treated with chemoradiation for rectal cancer.
    Kaminski A; Joseph D; Elsaleh H
    Australas Radiol; 2007 Jun; 51(3):283-8. PubMed ID: 17504322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of advanced rectal cancer responding to 5-fluorouracil based preoperative chemoradiation therapy].
    Ikemoto T; Nishioka M; Ando T; Yawata Y; Terashima Y; Ikushima H; Shimada M
    Gan To Kagaku Ryoho; 2005 Jan; 32(1):95-7. PubMed ID: 15675591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Phase I trial of preoperative eniluracil plus 5-fluorouracil and radiation for locally advanced or unresectable adenocarcinoma of the rectum and colon.
    Czito BG; Hong TJ; Cohen DP; Tyler DS; Lee CG; Anscher MS; Ludwig KA; Seigler HF; Mantyh C; Morse MA; Lockhart AC; Petros WP; Honeycutt W; Spector NL; Ertel PJ; Mangum SG; Hurwitz HI
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):779-85. PubMed ID: 14967434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors for disease-free survival in patients with T3-4 or N+ rectal cancer treated with preoperative chemoradiation therapy, surgery, and intraoperative irradiation.
    Díaz-González JA; Calvo FA; Cortés J; García-Sabrido JL; Gómez-Espí M; Del Valle E; Muñoz-Jiménez F; Alvarez E
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1122-8. PubMed ID: 16406393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized clinical trial of adjuvant radiotherapy and 5-fluorouracil infusion in colorectal cancer (AXIS).
    James RD; Donaldson D; Gray R; Northover JM; Stenning SP; Taylor I;
    Br J Surg; 2003 Oct; 90(10):1200-12. PubMed ID: 14515287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II trial of preoperative chemoradiation with a hyperfractionated radiation boost in locally advanced rectal cancer.
    Movsas B; Diratzouian H; Hanlon A; Cooper H; Freedman G; Konski A; Sigurdson E; Hoffman J; Meropol NJ; Weiner LM; Coia L; Lanciano R; Stein J; Kister D; Eisenberg B
    Am J Clin Oncol; 2006 Oct; 29(5):435-41. PubMed ID: 17023775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoradiotherapy followed by surgery in rectal cancer: improved local control using a moderately high pelvic radiation dose.
    Lee SH; Lee KC; Choi JH; Oh JH; Baek JH; Park SH; Shin DB
    Jpn J Clin Oncol; 2008 Feb; 38(2):112-21. PubMed ID: 18263881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Rectal cancer: treatment and results].
    Luna Pérez P
    Rev Invest Clin; 2001; 53(1):65-76. PubMed ID: 11332053
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term results of a phase II trial of high-dose radiotherapy (60 Gy) and UFT/l-leucovorin in patients with non-resectable locally advanced rectal cancer (LARC).
    Vestermark LW; Jacobsen A; Qvortrup C; Hansen F; Bisgaard C; Baatrup G; Rasmussen P; Pfeiffer P
    Acta Oncol; 2008; 47(3):428-33. PubMed ID: 18348002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is final TNM staging a predictor for survival in locally advanced rectal cancer after preoperative chemoradiation therapy?
    Kuo LJ; Liu MC; Jian JJ; Horng CF; Cheng TI; Chen CM; Fang WT; Chung YL
    Ann Surg Oncol; 2007 Oct; 14(10):2766-72. PubMed ID: 17551794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative chemoradiotherapy for rectal cancer: randomized trial comparing oral uracil and tegafur and oral leucovorin vs. intravenous 5-fluorouracil and leucovorin.
    de la Torre A; García-Berrocal MI; Arias F; Mariño A; Valcárcel F; Magallón R; Regueiro CA; Romero J; Zapata I; de la Fuente C; Fernández-Lizarbe E; Vergara G; Belinchón B; Veiras M; Molerón R; Millán I
    Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):102-10. PubMed ID: 17869446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic value of lymph node metastases and tumour regression grade in rectal cancer patients treated with long-course preoperative chemoradiotherapy.
    Lindebjerg J; Spindler KL; Ploen J; Jakobsen A
    Colorectal Dis; 2009 Mar; 11(3):264-9. PubMed ID: 18573119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preoperative intraluminal 5-FU osmosis chemotherapy as an adjuvant to radical resection for rectal cancer].
    Lu J; Zhao L; Liu L
    Zhonghua Wai Ke Za Zhi; 1996 Jan; 34(1):54-6. PubMed ID: 9275691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of the comparative toxicity of 5-FU bolus versus 5-FU continuous infusion circadian chemotherapy with concurrent radiation therapy in locally advanced rectal cancer.
    Thrall MM; Wood P; King V; Rivera W; Hrushesky W
    Int J Radiat Oncol Biol Phys; 2000 Mar; 46(4):873-81. PubMed ID: 10705008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-operative concurrent chemoradiation therapy using oral uracil-tegafur versus weekly intravenous fluorouracil for locally advanced rectal cancer.
    Hsieh CH; Chen YJ; Chang KH; Hsu HH; Liu CK; Hung SK; Chen HW; Lai YL; Hsu TC
    Anticancer Res; 2006; 26(5B):3709-15. PubMed ID: 17094389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203.
    Gérard JP; Conroy T; Bonnetain F; Bouché O; Chapet O; Closon-Dejardin MT; Untereiner M; Leduc B; Francois E; Maurel J; Seitz JF; Buecher B; Mackiewicz R; Ducreux M; Bedenne L
    J Clin Oncol; 2006 Oct; 24(28):4620-5. PubMed ID: 17008704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathology of rectal adenocarcinoma following preoperative adjuvant radiotherapy and chemotherapy.
    Allen DC; Fon LJ; McAleer JJ; Irwin ST
    Ulster Med J; 1999 May; 68(1):17-21. PubMed ID: 10489807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of adjuvant chemoradiotherapy after a radical gastrectomy and a D2 node dissection for gastric adenocarcinoma.
    Leong CN; Chung HT; Lee KM; Shakespeare TP; Mukherjee RK; Wong LC; Lu JJ; Tey J; Lim R; So JB; Back MF
    Cancer J; 2008; 14(4):269-75. PubMed ID: 18677137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early results from a phase I/II radiation dose-escalation study with concurrent amifostine and infusional 5-fluorouracil chemotherapy for preoperative treatment of unresectable or locally recurrent rectal carcinoma.
    Myerson R; Zobeiri I; Birnbaum E; Dietz D; Fleshman J; Kodner I; Picus J; Ratkin G
    Semin Oncol; 2002 Dec; 29(6 Suppl 19):29-33. PubMed ID: 12577240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy.
    Beddy D; Hyland JM; Winter DC; Lim C; White A; Moriarty M; Armstrong J; Fennelly D; Gibbons D; Sheahan K
    Ann Surg Oncol; 2008 Dec; 15(12):3471-7. PubMed ID: 18846402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.